POC Cholesterol Testing Market

   Single User - $995
   Site License (one location, 10 users) - $1,495
   Corporate License - $1,990

Published Jan 26, 2016 | 37 Pages | Pub ID: KLI5856829

Point of Care (POC) Cholesterol Testing Market

Point of care (POC) tests – diagnostic tests that are performed at or near the site where the patient is located – may be performed by laboratory personnel, but often are performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). The menu for POC testing includes cholesterol testing. Point of Care (POC) Cholesterol Testing Market analyzes the market for this segment of POC testing.

The report examines the following components of the POC cholesterol market:
  • Global POC Cholesterol Testing Market Analysis, 2012-2020
  • POC Cholesterol Self-Testing Market Analysis, 2015 and 2020
  • POC Cholesterol Professional Testing Market Analysis, 2015 and 2020
  • Global POC Cholesterol Testing Market Revenues and Market Share of Leading Suppliers, 2014
  • Global POC Cholesterol Testing Manufacturers by Percent, 2014
One of the key benefits and market drivers for the point of care (POC) testing market is the ability to have rapid results that can be used immediately for patient treatment decisions.

The professional sector is made up of tests used in hospitals, physician offices and clinics. In the core lab, cholesterol testing has gained importance, driven by growing awareness about the risks of heart attack and increasing realization among individuals to control their cholesterol levels. Overall growth in testing volume is driven by factors such as aging population and growing number of people at risk of cardiovascular disease including those with hypertension, diabetes mellitus, and abdominal obesity.

Industry professionals had anticipated that patient self-testing would grow because of rising consumer expectations, technological innovations, and the surge of consumer activism in healthcare. Further pharmacies, retail outlets and the physician office are establishing their position for patient wellness screening. Tests for UTIs, H. pylori, cholesterol PSA, TSH, drugs of abuse and others are readily available in all developed countries. However, these have not caught the imagination of consumers. One of the major issues is that of test interpretation, not so much of the actual result but what the result implies.

Cholesterol testing as an aid to diagnosis of cardiovascular disease and diabetes is discussed, as well as how cholesterol testing may be used in conjunction with the measurement of cardiac biomarkers.

The top and/or innovative competitors discussed within Corporate Profiles are:
  • Abaxis
  • Acon
  • Alere
  • Polymer Technologies
  • Roche
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times